Intensity Therapeutics (INTS) Prepaid Assets (2022 - 2026)
Intensity Therapeutics' (INTS) quarterly Prepaid Assets came in at $661000.0 in Q1 2026, down 8.45% YoY from $722000.0 in Q1 2025, and down 16.12% on a QoQ basis from $788000.0 in Q4 2025.
Intensity Therapeutics (INTS) Prepaid Assets (2022 - 2026) Analysis & Trends
Intensity Therapeutics (INTS) has 5 years of Prepaid Assets data on file, last reported at $661000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 8.45% year-over-year to $661000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $661000.0 (down 8.45% YoY) and the FY2025 annual result came in at $788000.0, up 1.94% from the prior year.
- Prepaid Assets declined to $661000.0 in Q1 2026, from $788000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.1 million in Q3 2025 to a low of $53432.0 in Q3 2023.
- A 5-year average of $664760.9 and a median of $722000.0 in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 1780.9% — and 2025, when it retreated 26.34%.
- Tracing INTS's Prepaid Assets over 5 years: stood at $63000.0 in 2022, then soared by 992.06% to $688000.0 in 2023, then grew by 12.35% to $773000.0 in 2024, then grew by 1.94% to $788000.0 in 2025, then slipped by 16.12% to $661000.0 in 2026.
- The last three Prepaid Assets figures came in at $661000.0 (Q1 2026), $788000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Intensity Therapeutics | 13.06 Mn | 13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | 661,000.00 |
| Dec 31, 2025 | 788,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 822,000.00 |
| Mar 31, 2025 | 722,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 672,000.00 |
| Dec 31, 2023 | 688,000.00 |
| Sep 30, 2023 | 53,432.00 |
| Jun 30, 2023 | 159,460.00 |
| Dec 31, 2022 | 63,000.00 |